FDA Medical devices recall ·

VersaCross RF Wire (VXW) recall

Recall number
Z-2104-2025
Date
(initiated June 10, 2025)
Company / brand
Boston Scientific Corporation
4100 Hamline Ave N, Saint Paul, MN, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
14,724
Hazard tags
Sterility
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.

Why was it recalled?

Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

UDI-DI 00685447006121 Lot 35935598

Distribution

Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-2104-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.